Kadcyla 160mg (Trastuzumab emtansine Vials) 160mg

Kadcyla 160mg (trastuzumab emtansine) is an antibody-drug conjugate used in cancer therapy. This 160mg vial form is designed for intravenous administration under medical supervision. Store between 2-8°C to maintain stability. Always consult a healthcare professional before use.

Strength

160mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Roche Pharma Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trastuzumab emtansine is primarily used to treat certain types of HER2-positive breast cancer. It combines the targeting ability of trastuzumab with the cell-killing action of emtansine. This medication is often prescribed after prior HER2-targeted therapy. Patients may ask 'what is trastuzumab emtansine used for' when seeking targeted cancer treatments.

Side Effects

This medication works by delivering chemotherapy directly to cancer cells while sparing healthy tissue. Patients may experience effects such as fatigue, nausea, or headache during treatment. Some people report changes in appetite or temporary hair thinning. These effects vary widely between individuals.

Precautions & Warnings

Kadcyla requires careful handling and administration by healthcare professionals. Keep vials refrigerated between 2-8°C and protect from light. Avoid exposure to extreme temperatures or freezing. Always check expiration dates before use. Report any unusual symptoms to your medical provider immediately.

Avoid Interactions

Certain medications may affect how trastuzumab emtansine works in the body. Strong CYP3A4 inhibitors or inducers can alter drug levels. Blood thinners and other cancer therapies may require dose adjustments. Always inform your doctor about all medications you're taking before starting this treatment.

Frequently Asked Questions

It is primarily used to treat HER2-positive breast cancer that has spread to other parts of the body or returned after previous treatment.

This medication is given as an intravenous infusion by healthcare professionals in a clinical setting.

Common effects include fatigue, nausea, headache, and temporary hair thinning. Always discuss side effects with your healthcare provider.

This medication requires a prescription and should only be obtained through licensed pharmacies or medical providers.

Store vials refrigerated between 2-8°C and protect from light until ready for use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.